Shopping Cart
- Remove All
- Your shopping cart is currently empty
RR-11a is a synthetic enzyme legumain inhibitor. This compound specifically targets and inhibits the activity of legumain, an enzyme implicated in various biological processes. RR-11a's synthetic nature allows for precise modulation of legumain activity, making it a valuable tool in biochemical research and potential therapeutic applications.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,980 | 7-10 days |
Description | RR-11a is a synthetic enzyme legumain inhibitor. This compound specifically targets and inhibits the activity of legumain, an enzyme implicated in various biological processes. RR-11a's synthetic nature allows for precise modulation of legumain activity, making it a valuable tool in biochemical research and potential therapeutic applications. |
Targets&IC50 | Legumain:31-55 nM (IC50) |
In vitro | Legumain-targeted nanoparticles coupled with RR-11a demonstrate substantial ligand-receptor affinity, thereby enabling enhanced penetration and uptake within solid tumors by tumor cells. |
In vivo | Tumor-bearing mice treated with RR-11a-coupled NPs encapsulating doxorubicin results in improved tumor selectivity and drug sensitivity, It completely inhibits tumor growth. |
Molecular Weight | 560.51 |
Formula | C24H28N6O10 |
Cas No. | 1361390-56-8 |
Relative Density. | no data available |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.